跳至主要内容
临床试验/NCT04835987
NCT04835987撤回不适用

Prospective Monocentric Evaluation of the Autonomic Nervous System in Patients Undergoing Esophagectomy for Cancer

Centre Hospitalier Universitaire de Saint Etienne1 个研究点 分布在 1 个国家开始时间: 2023年12月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Analysis of Standard deviation of all NN (SDNN) (ms)

研究概览

简要总结

Esophageal surgery is a complex surgery, with high post-operative morbidity and mortality. The incidence of complications associated with esophagectomy varies from 17% to 74%, in the literature. A section of vagus nerves is conventionally performed during esophagectomy for cancer, because of oncological margins. The vagus nerve is responsible for the parasympathetic innervation at the gastrointestinal level, but also at the cardiac and pulmonary level. The post-operative morbidity of these procedures could be linked in part to the bilateral section of the vagus nerves, because of their impact on the autonomous regulation of this vital functions. The main objective of the study is to find a modification of the sympathomimetic balance pre and post operatively, in patients undergoing esophagectomy.

详细描述

The sympathomimetic balance was measured using a Holter-ECG heart rate monitor. The parameters collected were used to calculate the variability of the heart rate, the high frequencies (HF, reflection of the parasympathetic system), the low frequencies (LF, reflection of the sympathetic system and the parasympathetic system) and the ratio // LF / HF (reflection of the sympathetic activity) thanks to Fourier analysis and the use of HRVanalysis software.

The measurements were taken at night, to overcome the great sympathomimetic variabilities due to external stimulations during the day: one night 3 month before surgery/before the first chemotherapy, one night between 2 and 4 weeks before hospitalization (remotely of possible chemotherapy), the night before the intervention (context of hospitalization and preoperative stress), one night between D7 and D10 (context of hospitalization, and distance from anesthetic drugs), one night at home between 4 and 8 weeks post-operative, and one night at home at 3 months post-operative.

The measurements were therefore not carried out the first nights following the intervention to overcome the anesthetic drugs that affect the balance of the autonomic nervous system.

A baroreflex measurement was carried out at the patient's entrance, the day before the intervention, during hospitalization, and the day of discharge. This measure was renewed at 3 months.

A measurement of patient activity was carried out preoperatively by wearing an actimeter watch for 1 week then renewed at 3 months.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Esophagectomy for cancer
  • written and oral agreement

排除标准

  • pregnant women,
  • patients with permanent atrial fibrillation,
  • patients with pace-maker
  • Patients under guardianship/curatorship

结局指标

主要结局

Analysis of Standard deviation of all NN (SDNN) (ms)

时间窗: day 7 to day 90

Analysis of Standard deviation of all NN (SDNN) intervals, over the entire registration period, provides information on global variability. Measured by Holter results. Day 0 = surgery

次要结局

  • LF/HF ratio(after surgery : day 7, day 60, day 90)
  • HF activity(after surgery : day 7, day 60, day 90)
  • change in baroreflex(Day -1, Day 7, day discharge, day 90)
  • modify the respiratory functional exploration(Day -30, Day 30, Day 60)
  • physical capacity(Day-30, Day 30, Day 90)
  • LF activity(after surgery : day 7, day 60, day 90)
  • intraoperative pupillometry(during surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

终止
不适用
Esophageal Multisegmented FCSEMS for Malignant StricturesOesophageal CancerEsophageal Stent Stenosis
NCT04415463Radboud University Medical Center23
已完成
4 期
Deep Neuromuscular Relaxation in Patients for Thoraco-laparoscopic EsophagectomyNeuromuscular BlockSurgeryEsophageal Cancer
NCT02320734Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)66
已完成
4 期
Intralesional Steroid Injection Versus Oral Prednisolone in Prevention of Esophageal StrictureEsophageal Stenosis
NCT04498260Instituto do Cancer do Estado de São Paulo30
终止
不适用
Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or ChemotherapyStage I Adenoid Cystic Carcinoma of the Oral CavityStage I Mucoepidermoid Carcinoma of the Oral CavityStage I Squamous Cell Carcinoma of the HypopharynxStage I Squamous Cell Carcinoma of the LarynxStage I Squamous Cell Carcinoma of the Lip and Oral CavityStage I Verrucous Carcinoma of the LarynxStage I Verrucous Carcinoma of the Oral CavityStage II Adenoid Cystic Carcinoma of the Oral CavityStage II Mucoepidermoid Carcinoma of the Oral CavityStage II Squamous Cell Carcinoma of the HypopharynxStage II Squamous Cell Carcinoma of the LarynxStage II Squamous Cell Carcinoma of the Lip and Oral CavityStage II Verrucous Carcinoma of the LarynxStage II Verrucous Carcinoma of the Oral CavityStage III Adenoid Cystic Carcinoma of the Oral CavityStage III Mucoepidermoid Carcinoma of the Oral CavityStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral CavityStage III Verrucous Carcinoma of the LarynxStage III Verrucous Carcinoma of the Oral CavityStage IV Adenoid Cystic Carcinoma of the Oral CavityStage IV Mucoepidermoid Carcinoma of the Oral CavityStage IV Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the LarynxStage IV Squamous Cell Carcinoma of the Lip and Oral CavityStage IV Verrucous Carcinoma of the LarynxStage IV Verrucous Carcinoma of the Oral Cavity
NCT01164566Wake Forest University Health Sciences6
终止
不适用
An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of RefluxGastroesophageal Reflux Disease (GERD)Reflux, GastroesophagealAcid RefluxGastroesophageal Reflux
NCT02749071EndoStim Inc.161